SFS
RYTM icon

Sowell Financial Services’s Rhythm Pharmaceuticals RYTM Stock Holding History

Sowell Financial Services’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-402
Closed -$9K – 2288
2021
Q1 		$9K Buy
+402
New +$11.7K ﹤0.01% 2368

Other funds holding RYTM

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Sowell Financial Services's RYTM Position: Q2 2021 in Review

Sowell Financial Services sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2021, closing a stake of 402 shares — an estimated $9K sold.

Sowell Financial Services first reported a position in RYTM in Q1 2021 and held it in 1 quarter. The position peaked at $9K in Q1 2021. 105 funds tracked by Wall St. Rank hold RYTM as of Q2 2021.

  • Sowell Financial Services reported no remaining Rhythm Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 402 Rhythm Pharmaceuticals shares in Q2 2021, an estimated $9K.
  • Sowell Financial Services first reported a position in Rhythm Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Rhythm Pharmaceuticals position peaked at $9K in Q1 2021.
  • 105 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.